Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a new drug, varenicline, for smoking cessation
is more effective than the standard nicotine replacement therapy aide currently used, "the
patch" among smokers hospitalized with coronary heart disease.